RSP - Cancer solid

Aus coViki
Wechseln zu: Navigation, Suche
  • GET ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak Extract
  • GET 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak Extract
  • GET ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment Extract
  • GET 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors Extract
  • GET ä. What the oncologist needs to know about COVID-19 infection in cancer patients Extract
  • GET ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ? Extract
  • GET 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak Extract
  • GET 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection Extract
  • GET ä. COVID-19 and cancer: what we know so far Extract
  • GET 2020. COVID-19 More Frequent, Severe in Cancer Patients Extract
  • GET 2020. COVID-19 infection in cancer patients: early observations and unanswered questions Extract
  • GET 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China Extract
  • GET 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte) Extract
  • GET 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab Extract
  • GET 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome Extract
  • GET ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak Extract
  • GET 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ... Extract
  • GET 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency? Extract
Meine Werkzeuge